INSIGHTEC SIGNS DISTRIBUTION AGREEMENTS IN INDIA, AUSTRALIA, AND TURKEY
INSIGHTEC, the leader in MR guided Focused Ultrasound (MRgFUS) therapy today announced it has signed new distribution agreements with 3 new partners: Biomed Healthtech in the Indian market, Medigroup, as a representative in Australia and New Zealand, and LEVI Group, in the Turkish market.
“Biomed Healthtech is committed to providing medical devices that enable care providers and health systems to offer better care for their patients," said Dr. Mukesh Daftary, Managing Director of Biomed Healthtech (Mumbai, India). “In my many years in Healthcare I have not seen such an excitement for a new technology. I have no doubt in my mind that this technology will revolutionize healthcare as we know it” he added. Biomed Healthtech will be collaborating with an INSIGHTEC representative in India, Mr. Srinivas Sundaraj.
Chris Selwa, Managing Director of Medigroup EBI (Melbourne, Australia), noted "Medigroup EBI introduces ground breaking medical technologies for our healthcare providers. We believe Exablate Neuro and Exablate are ground breaking therapy platforms that we are excited to add to our neurosurgical and general surgical team's portfolios. In the short term, treating Essential Tremor, Parkinson’s Disease associated tremor and uterine fibroids under MRI without surgery are very significant advances Medigroup EBI's team looks forward to introducing. Add to this some new indications, such as manipulation of the blood brain barrier for targeted therapeutic delivery, which can potentially transform patient treatments in Australia and New Zealand". Medigroup will be collaborating with an INSIGHTEC representative in Australia, Mr. Elad Guberman, from IBD Consulting.
“Non-invasive treatment options for neurology, oncology and women’s health indications are critical issues for many patients, and offering INSIGHTEC’s Exablate system will provide additional choice for healthcare providers,” said Mr. Alber Bicaci of LEVI Group (Istanbul, Turkey). LEVI Group’s plan is to offer a dedicated commercial team to support the promotion of INSIGHTEC’s Exablate Neuro and Exablate therapy platforms in Turkey for the benefit of our providers and patients alike,” he emphasized.
“We are pleased to have signed these distribution agreements for ExAblate and ExAblate Neuro in India, Australia, and Turkey,” said Roni Yagel, Vice President of International Markets for INSIGHTEC. “Our partners provide strong sales, marketing and distribution capabilities for INSIGHTEC in the mentioned markets. We believe Asia and Oceania are significant markets for INSIGHTEC and represent an important presence as we introduce and expand our technology’s footprint in these regions”.
The distribution agreements may be expanded with additional products and indications in the future. Financial terms of the agreement were not disclosed.